دورية أكاديمية

Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study

التفاصيل البيبلوغرافية
العنوان: Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
المؤلفون: Wu, Yi-Long, Yang, Jin-Ji, Zhou, Jianying, Liu, Si-Yang Maggie, Li, Mingjun, Zhang, Zhiye, Cheng, Ying, Fan, Yun, Pan, Hongming, Wang, Baoqing, Chen, Gongyan, Wang, Ke, Jiang, Liyan, Hu, Yanping, Shi, Jianhua, Dong, Xiaorong, Ding, Cuimin, Liu, Yunpeng, Liu, Zhe, Liao, Wangjun, Li, Wei, Wang, Jun, Yi, Shanyong, Zhao, Qiong, Zang, Aimin, Chen, Yuan, Cui, Jiuwei, Luo, Pengfei, Shen, Xionghu, Sun, Meili, Wang, Changli, Zhou, Yongchun, Wu, Zhuli, Wang, Xingli, Sun, Juan, Guo, Jiayan, Zheng, Yang, Xiang, Xiao, Hui, Ai-min
المصدر: In The Lancet Respiratory Medicine September 2024 12(9):671-680
قاعدة البيانات: ScienceDirect
الوصف
تدمد:22132600
DOI:10.1016/S2213-2600(24)00171-1